Press Releases
Breaking News: TheraBionic Inc. announces FDA Approval of New Medical Device to Treat Advanced Liver Cancer
TheraBionic P1 device is the First FDA-Approved Therapy Using Radiofrequency Electromagnetic Fields for the Systemic Targeted Treatment of Cancer
Wake Forest School of Medicine Research shows radio-wave therapy is safe for liver cancer patients and improves overall survival
Triad Business Journal – September 18, 2021
Radio Waves Show Promise in Treating Hepatocellular Carcinomats
Managed Healthcare EXECUTIVE – September 2, 2021
Radio-waves improve survival in liver cancer patients
LAB + LIFE Scientist – August 17, 2021
Radio-wave therapy proves effective against liver cancer cells
MEDICAL PRESS – MAY 31, 2019
Revolutionary Electromedical Cancer Treatment Approved by EU
STATIN NATION – August 31, 2018
TheraBionic P1 device receives European regulatory approval
THE CANCER LETTER – August 3, 2018
Tumor-Treating Field Therapy Looks Beyond Brain Cancer
OncLive – July 31, 2018